相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
K. Yamaguchi et al.
ONCOGENE (2010)
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok et al.
CANCER CELL (2009)
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer
Margarita Aponte et al.
CANCER RESEARCH (2008)
Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy
Joshua Z. Press et al.
GYNECOLOGIC ONCOLOGY (2008)
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer
Charles N. Landen et al.
CANCER RESEARCH (2007)
Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy
John M. L. Ebos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance
M. Kilic et al.
ONCOGENE (2007)
Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1α
Meng-Hsing Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Thromboembolic complications in patients with clear cell carcinoma of the ovary
Yusuke Matsuura et al.
GYNECOLOGIC ONCOLOGY (2007)
Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways
Rong Wu et al.
CANCER CELL (2007)
Expression of HIF-1α, HIF-2α (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations
Patrick J. Pollard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
M. J. Cuadrado et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1
Ori Nevo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy
Jyotsnabaran Halder et al.
CLINICAL CANCER RESEARCH (2006)
被撤回的出版物: Down-regulation of Notch-1 inhibits invasion by inactivation of nuclear Factor-κB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. (Retracted article. See vol. 78, pg. 5476, 2018)
ZW Wang et al.
CANCER RESEARCH (2006)
Treatment issues in clear cell carcinoma of the ovary: A different entity?
Dimitrios Pectasides et al.
ONCOLOGIST (2006)
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
T Bonome et al.
CANCER RESEARCH (2005)
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
KK Zorn et al.
CLINICAL CANCER RESEARCH (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
The proinflammatory cytokine interleukin 1β and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation
S Frede et al.
CANCER RESEARCH (2005)
Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression
GY Gwak et al.
JOURNAL OF HEPATOLOGY (2005)
Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism
M Ciofani et al.
NATURE IMMUNOLOGY (2005)
Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models
CH Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy
V Poulaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Crucial role of activin a in tubulogenesis of endothelial cells induced by vascular endothelial growth factor
K Maeshima et al.
ENDOCRINOLOGY (2004)
Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways
H Donninger et al.
ONCOGENE (2004)
Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1
BD Kelly et al.
CIRCULATION RESEARCH (2003)
Dominant-negative hypoxia-inducible factor-1α reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism
J Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase
L Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Signal transduction by VEGF receptor-1 wild type and mutant proteins
N Ito et al.
CELLULAR SIGNALLING (2001)
Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase
VM Gitlits et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2001)
分享论文
